Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4621)
All Articles published online
|
Jun 21, 2012 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Yang J, Zhang JX, Wang H, Wang GL, Hu QG, Zheng QC. Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i23/2938.htm |
| Number | Citing Articles |
| 1 |
Zhiwu Tan, Mei Sum Chiu, Xinxiang Yang, Ming Yue, Tan To Cheung, Dongyan Zhou, Yuewen Wang, Anthony Wing-Hung Chan, Chi Wing Yan, Ka Yi Kwan, Yik Chun Wong, Xin Li, Jingying Zhou, Ka Fai To, Jiye Zhu, Chung Mau Lo, Alfred Sze-Lok Cheng, Stephen Lam Chan, Li Liu, You-Qiang Song, Kwan Man, Zhiwei Chen. Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patients. Gut 2023; 72(8): 1568 doi: 10.1136/gutjnl-2022-327133
|
| 2 |
Clara Martori, Lidia Sanchez-Moral, Tony Paul, Juan Carlos Pardo, Albert Font, Vicenç Ruiz de Porras, Maria-Rosa Sarrias. Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?. Cancers 2022; 14(2): 440 doi: 10.3390/cancers14020440
|
| 3 |
Chen Chen, Zehua Wang, Yi Ding, Yanru Qin. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1133308
|
| 4 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 121 doi: 10.1007/978-3-319-26956-6_5
|
| 5 |
Jingchang Zhang, Renfeng Li, Shuai Huang. The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.951019
|
| 6 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_5-1
|
| 7 |
Zhe Gong, Jieyun Zhang, Weijian Guo. Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer. Cancer Medicine 2020; 9(23): 9052 doi: 10.1002/cam4.3505
|
| 8 |
Firdosh Shah, Mitesh Kumar Dwivedi. Probiotics in Anticancer Immunity. 2023; : 189 doi: 10.2174/9789815124781123030011
|
| 9 |
Qi Zhang, Yu Lou, Xue-Li Bai, Ting-Bo Liang. Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression. World Journal of Gastroenterology 2018; 24(31): 3500-3512 doi: 10.3748/wjg.v24.i31.3500
|
| 10 |
Han Wang, Allan Tsung, Lopa Mishra, Hai Huang. Regulatory T cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinoma. eBioMedicine 2024; 101: 105031 doi: 10.1016/j.ebiom.2024.105031
|
| 11 |
Shreya Sharma, Ritu Khosla, Paul David, Archana Rastogi, Ashish Vyas, Dileep Singh, Ankit Bhardwaj, Amrish Sahney, Rakhi Maiwall, Shiv Kumar Sarin, Nirupma Trehanpati. CD4+CD25+CD127low Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma. Frontiers in Immunology 2015; 6 doi: 10.3389/fimmu.2015.00049
|
| 12 |
Maria Grazia Refolo, Caterina Messa, Vito Guerra, Brian Irving Carr, Rosalba D’Alessandro. Inflammatory Mechanisms of HCC Development. Cancers 2020; 12(3): 641 doi: 10.3390/cancers12030641
|
| 13 |
Egidijus Morkunas, Evelina Vaitkeviciute, Greta Varkalaite, Vidas Pilvinis, Jurgita Skieceviciene, Juozas Kupcinskas. Diagnostic and Prognostic Value of IL-10, FABP2 and LPS Levels in HCC Patients. Medicina 2023; 59(12): 2191 doi: 10.3390/medicina59122191
|
| 14 |
Bahareh Kashani, Zahra Zandi, Atieh Pourbagheri‐Sigaroodi, Davood Bashash, Seyed H. Ghaffari. The role of toll‐like receptor 4 (TLR4) in cancer progression: A possible therapeutic target?. Journal of Cellular Physiology 2021; 236(6): 4121 doi: 10.1002/jcp.30166
|
| 15 |
Laurissa Ouaguia, Dhafer Mrizak, Sarah Renaud, Olivier Moralès, Nadira Delhem. Control of the Inflammatory Response Mechanisms Mediated by Natural and Induced Regulatory T-Cells in HCV-, HTLV-1-, and EBV-Associated Cancers. Mediators of Inflammation 2014; 2014: 1 doi: 10.1155/2014/564296
|
| 16 |
An Zhou, Li Tang, Shuo Zeng, Yuanyuan Lei, Shiming Yang, Bo Tang. Gut microbiota: A new piece in understanding hepatocarcinogenesis. Cancer Letters 2020; 474: 15 doi: 10.1016/j.canlet.2020.01.002
|
| 17 |
Bo Hu, Jian‐Zhen Lin, Xiao‐Bo Yang, Xin‐Ting Sang. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review. Cell Proliferation 2020; 53(3) doi: 10.1111/cpr.12772
|
| 18 |
Xiaonan Xiang, Jianguo Wang, Di Lu, Xiao Xu. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduction and Targeted Therapy 2021; 6(1) doi: 10.1038/s41392-021-00484-9
|
| 19 |
Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna E. Stergiou, Vasileios Lekakis, Spyridon Davakis, Maria-Ioanna Christodoulou, Georgios Germanidis, Stamatios Theocharis. The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks?. Cancers 2023; 15(10): 2795 doi: 10.3390/cancers15102795
|
| 20 |
Oscar W.H. Yeung, Chung-Mau Lo, Chang-Chun Ling, Xiang Qi, Wei Geng, Chang-Xian Li, Kevin T.P. Ng, Stuart J. Forbes, Xin-Yuan Guan, Ronnie T.P. Poon, Sheung-Tat Fan, Kwan Man. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. Journal of Hepatology 2015; 62(3): 607 doi: 10.1016/j.jhep.2014.10.029
|
| 21 |
Zahra Sepehri, Zohre Kiani, Farhad Kohan, Seyed Moayed Alavian, Saeid Ghavami. Toll like receptor 4 and hepatocellular carcinoma; A systematic review. Life Sciences 2017; 179: 80 doi: 10.1016/j.lfs.2017.04.025
|
| 22 |
Seung-Jin Kim, Dipendra Khadka, Jae Ho Seo. Interplay between Solid Tumors and Tumor Microenvironment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.882718
|
| 23 |
Yang Liu, Xi Zhang, Junjun Zhang, Juan Tan, Jie Li, Zewen Song. Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.596679
|
| 24 |
Jianfeng Xiang, Xinrui Wu, Wangrui Liu, Huagen Wei, Zhu Zhu, Shifan Liu, Chengqi Song, Qiang Gu, Shiyin Wei, Yichi Zhang. Bioinformatic analyzes and validation of cystathionine gamma-lyase as a prognostic biomarker and related to immune infiltrates in hepatocellular carcinoma. Heliyon 2023; 9(5): e16152 doi: 10.1016/j.heliyon.2023.e16152
|
| 25 |
Qingqing Liu, Xiaoyu Yan, Runyuan Li, Yuan Yuan, Jian Wang, Yuanxin Zhao, Jiaying Fu, Jing Su. Polyamine Signal through HCC Microenvironment: A Key Regulator of Mitochondrial Preservation and Turnover in TAMs. International Journal of Molecular Sciences 2024; 25(2): 996 doi: 10.3390/ijms25020996
|
| 26 |
Yuanyuan Zheng, Yan Li, Jiao Feng, Jingjing Li, Jie Ji, Liwei Wu, Qiang Yu, Weiqi Dai, Jianye Wu, Yingqun Zhou, Chuanyong Guo. Cellular based immunotherapy for primary liver cancer. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-02030-5
|
| 27 |
Wang Yaping, Wang Zhe, Chu Zhuling, Li Ruolei, Fan Pengyu, Guo Lili, Ji Cheng, Zhang Bo, Liu Liuyin, Hou Guangdong, Wang Yaoling, Hou Niuniu, Ling Rui. The soldiers needed to be awakened: Tumor-infiltrating immune cells. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.988703
|
| 28 |
Xiaolin Wei, Wenjing Zheng, Peikai Tian, Hui Liu, Yong He, Minjie Peng, Xiangde Liu, Xiaowu Li. Administration of glycyrrhetinic acid reinforces therapeutic effects of mesenchymal stem cell‐derived exosome against acute liver ischemia‐reperfusion injury. Journal of Cellular and Molecular Medicine 2020; 24(19): 11211 doi: 10.1111/jcmm.15675
|
| 29 |
Rachel M. Golonka, Matam Vijay-Kumar. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 171 doi: 10.1016/bs.acr.2020.10.004
|
| 30 |
|
| 31 |
Yu-Guang Chen, Chih-Wei Yang, Chi-Hsiang Chung, Ching-Liang Ho, Wei-Liang Chen, Wu-Chien Chien. The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study. Hepatology International 2022; 16(4): 807 doi: 10.1007/s12072-021-10281-9
|
| 32 |
Deepti Singh, Mohammad Afsar Khan, Hifzur R. Siddique. Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers. Life Sciences 2021; 285: 120008 doi: 10.1016/j.lfs.2021.120008
|
| 33 |
Greta Pessino, Claudia Scotti, Maristella Maggi. Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets. Cancers 2024; 16(5): 901 doi: 10.3390/cancers16050901
|
| 34 |
María Guadalupe Reyes García, Fernando García Tamayo. The Importance of the Nurse Cells and Regulatory Cells in the Control of T Lymphocyte Responses. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/352414
|
| 35 |
Thomas Tu, Magdalena Budzinska, Annette Maczurek, Robert Cheng, Anna Di Bartolomeo, Fiona Warner, Geoffrey McCaughan, Susan McLennan, Nicholas Shackel. Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development. International Journal of Molecular Sciences 2014; 15(6): 9422 doi: 10.3390/ijms15069422
|
| 36 |
Yuanfei Lu, Na Feng, Yongzhong Du, Risheng Yu. Nanoparticle-Based Therapeutics to Overcome Obstacles in the Tumor Microenvironment of Hepatocellular Carcinoma. Nanomaterials 2022; 12(16): 2832 doi: 10.3390/nano12162832
|
| 37 |
Xiaoqin Zheng, Wenjie Jin, Shanshan Wang, Huiguo Ding. Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.729705
|
| 38 |
Wenyu Luo, Shiqi Guo, Yang Zhou, Jingwen Zhao, Mengyao Wang, Lixuan Sang, Bing Chang, Bingyuan Wang. Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.873160
|